ACS Boss Talk

Vice President of Discovery Sciences Mark Noe takes us behind the scenes to help us better understand how the vaccination came to be

Amy Ripka, CEO, Lucy Therapeutics discusses leadership strategy, drug discovery and her passion for violin

Karin Briner, VP, Global Discovery Chemistry with Novartis, also projects what she sees for the future

Victor Aguilar, P&G’s Chief Research, Development and Innovation Officer, tells us what fuels his passion for inclusivity

As part of our ACS Boss Talk feature in 2020, we posed hundreds of questions to leading industry executives. Here are some of the most interesting responses we received last year

Fourteen industry executives reveal their answers

William Provine, President and CEO, Delaware Innovation Space, explains why you should view these experiences as ‘learnings’ vs. Success/failure

Jag Reddy, Grace’s Vice President of Strategy and Growth, shares how this model has helped him master the skill of multi-tasking

Stephan Habif, Senior Vice President, Research & Innovation, tells us how ‘universalization’ plays a key role

Carlonda R. Reilly, Kennametal’s VP and CTO, also tells us about the technology trends she is closely monitoring

CEO Jennifer Holmgren explains how Lanzatech makes a conscious effort to avoid the risks of falling into this trap

Amgen’s Margaret Faul explains why she has a passion for working with others and speaks to the essential traits for successful leaders of people

Merck’s Head of Discovery Emma Parmee compares discovering and inventing medicines to “looking for a needle in a haystack”

Dow’s Karen Carter shares what made the experience so unforgettable

Genentech’s Dan Sutherlin provides his outlook and speaks to the adaptations the company has made during COVID-19